Personalized Medicine – Products

Affymetrix, Inc. announced that its GeneChip® System 3000Dx v.2 (GCS 3000Dx v.2) has been approved by China's State Food and Drug Administration (SFDA) for in vitro diagnostic use.

These presentations represent the first re-sequencing data ever generated using a single-molecule, solid-state DNA sequencing platform.

High-throughput DNA sequencing technologies are leading to a revolution in how clinicians diagnose and treat cancer. The molecular profiles of individual tumors are beginning to be used in the design of chemotherapeutic programs optimized for the treatment of individual patients.

The Center for Human Genetics and Laboratory Medicine and IMGM Laboratories reported using the benchtop system to sequence clinically relevant exons and identify genomic variations in solid tumors treated with an antibody-based medicine.

New histology line-up addresses inconsistent preparation of samples in biomedical research and diagnostics.

New Comprehensive MDx LIMS Designed Specifically for Molecular Diagnostics Laboratories

Genedata Expressionist® raises the bar on scalability for data analysis of transcriptomics, genomics, and epigenetics

Labceutics to help pharmaceutical companies and their diagnostic partners gain easier, more cost effective access to high quality test results for physicians and patients.

Cambio to supply kits from Epicentre®, including those based on the company’s revolutionary Nextera technology for DNA sample preparation.

Acquisition of Intrinsic Bioprobes adds unique sample-preparation consumables for quantitative mass spectrometry.